Nicholas Grund

Insider Reports History

Location
Cambridge, MA
Signature
/s/ Carolyn M. Rucci, attorney-in-fact for Nicholas Grund
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Nicholas Grund:

Company Role Class Num Shares Value Price $ Report Date Ownership
Akebia Therapeutics, Inc. Chief Commercial Officer Common Stock 561,750 $780,832 $1.39 02 Feb 2026 Direct
Akebia Therapeutics, Inc. Chief Commercial Officer Stock Option (Right to buy) 320,000 30 Jan 2026 Direct

Insider Reports Filed by Nicholas Grund

Symbol Company Period Transactions Value $ Form Type Role Filing Time
AKBA Akebia Therapeutics, Inc. 02 Feb 2026 2 -$117,912 4 Chief Commercial Officer 04 Feb 2026, 16:13
AKBA Akebia Therapeutics, Inc. 30 Jan 2026 2 $0 4 Chief Commercial Officer 03 Feb 2026, 16:42
AKBA Akebia Therapeutics, Inc. 31 Jan 2025 3 -$116,804 4 Chief Commercial Officer 04 Feb 2025, 17:51
AKBA Akebia Therapeutics, Inc. 31 Jan 2024 2 $0 4 Chief Commercial Officer 02 Feb 2024, 16:11
AKBA Akebia Therapeutics, Inc. 08 Jan 2024 0 $0 3 Chief Commercial Officer 18 Jan 2024, 17:21